Kevin Taylor
Geschäftsführer bei Galvanize Therapeutics, Inc.
Profil
Kevin Taylor is currently the Chief Operating Officer at Galvanize Therapeutics, Inc. Prior to this, he worked as the Director of Process & Product Development at Acclarent, Inc., Principal at Atrionix, Inc., and Vice President of Development & Operations at ReCor Medical, Inc. He received his undergraduate degree from Drexel University and his MBA from The University of Chicago Booth School of Business.
Aktive Positionen von Kevin Taylor
| Unternehmen | Position | Beginn |
|---|---|---|
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Kevin Taylor
| Unternehmen | Position | Ende |
|---|---|---|
Acclarent, Inc.
 Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
Atrionix, Inc.
 Atrionix, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million. | Corporate Officer/Principal | - |
ReCor Medical, Inc.
 ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Geschäftsführer | - |
Ausbildung von Kevin Taylor
| Drexel University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ReCor Medical, Inc.
ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Health Technology |
Acclarent, Inc.
Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Health Technology |
Atrionix, Inc.
Atrionix, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million. | Health Technology |
Galvanize Therapeutics, Inc.
Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Commercial Services |
